This "Company Business Analysis and Segment Overview" (CBASO) is designed to provide a concise executive summary of a leading company in a particular industry and that company's applicable sector focus.

This CBASO details Cytyc's move into the women's health therapeutic devices area and outlines the dangers and opportunities in this competitive space. It provides a strategic analysis of the Cytyc ThinPrep cytology device: its strengths, opportunities, weaknesses and threats. In the process, this CBASO examines the functionality of the ThinPrep, detailing its features, pricing and operator deployments. It also looks at Cytyc's partners and third-party solutions providers.